For the quarter ending 2025-09-30, INVA had $78,981K increase in cash & cash equivalents over the period. $48,606K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 89,908 | 17,104 |
| Deferred income taxes | 4,949 | -877 |
| Amortization of capitalized fees and depreciation of property and equipment | 3,488 | 6,976 |
| Amortization of acquired intangible assets | 6,618 | 13,022 |
| Inventory fair value step-up adjustment included in cost of products sold | 3,484 | 625 |
| Stock-based compensation | 2,380 | 4,569 |
| Amortization of debt discount and issuance costs | 455 | 1,078 |
| Changes in fair values of equity method investments, net | 30,751 | -467 |
| Changes in fair values of equity and long-term investments, net | 31,510 | -54,019 |
| Acquired in-process research and development assets | 9,368 | - |
| Other non-cash items | 21 | -423 |
| Accounts receivable | 9,242 | 533 |
| Receivables from collaboration arrangement | -3,984 | 1,362 |
| Inventory | -6,847 | 17,146 |
| Prepaid expenses | 2,805 | -4,453 |
| Other assets | -227 | -774 |
| Accounts payable | 861 | 3,250 |
| Accrued personnel-related expenses and other accrued liabilities | -16,500 | 1,932 |
| Accrued interest payable | -3,187 | -4 |
| Income tax payable | 728 | 1,921 |
| Deferred revenue | 10,446 | 1,999 |
| Net cash provided by operating activities | 49,727 | 92,690 |
| Purchases of trading securities | 15,000 | 34,674 |
| Proceeds from trading securities | 0 | 5,097 |
| Purchases of equity investments managed by isp fund lp | 0 | 0 |
| Sales of equity investments managed by isp fund lp | 0 | 19,939 |
| Purchases and sales of other investments managed by isp fund lp, net | -43,901 | -8,086 |
| Purchases of property and equipment | 1,121 | - |
| Cash paid for in-process research and development assets acquired | 9,368 | - |
| Sale of property and equipment | 0 | 0 |
| Net cash provided by (used in) investing activities | 18,412 | -1,552 |
| Repurchase of common stock | 0 | 0 |
| Repurchase of shares to satisfy tax withholding | 25 | 91 |
| Proceeds from issuances of common stock, net | 194 | 1,521 |
| Proceeds from exercise of warrants | 10,698 | - |
| Payment for repurchase of convertible subordinated notes due 2025 | 25 | - |
| Net cash provided by (used in) financing activities | 10,842 | 1,430 |
| Net increase in cash and cash equivalents | 78,981 | 92,568 |
| Cash and cash equivalents at beginning of period | 304,964 | - |
| Cash and cash equivalents at end of period | 476,513 | - |
Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA)